Kartilage Cross is a single intra-articular injection treatment using patented IPN-Like Technology of hyaluronic acid cross-linking with the benefits of the antioxidant mannitol. It has been specifically designed by Laboratoires Vivacy to relieve the pain of osteoarthritis in joints such as the knee and hip.
If patients have not had success or had intolerance with painkillers, then Kartilage Cross works by restoring the lubricating and shock-absorbing properties of joint fluid, which are depleted in osteoarthritis.
- Ensures longevity of the product in the joint.
- Guarantees optimum viscoelasticity for shock absorption.
- Facilitates injection into all joint-related lesions.
Recommended for patients:
- who cannot comply with post-injection rest periods three weeks in a row.
- who dislike injections or want to minimise the number of injections.
- whose joints are difficult to access.